Beyondspring Pharmaceuticals News Today

Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Neutropenia Market (2023-2028) by Treatment, Distribution Channel, and Geography, Competitive...

/PRNewswire/ -- The "Global Neutropenia Market (2023-2028) by Treatment, Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19 and...

Jun 19, 2023 (The Expresswire) -- "Neutropenia Biologic Drug Treatment Market" Insights 2023 By Types (, By Drug Type, Filgrastim, Pegfilgrastim,...

Treatment with elranatamab monotherapy produced early, deep, and durable responses in patients with relapsed/refractory multiple myeloma who received a prior BCMA-directed therapy, according to a pooled analysis of the MagnetisMM-1, MagnetisMM-2, MagnetisMM-3, and MagnetisMM-9 trials.

Chinese stocks rebound, energy stocks such as Occidental surge, while Farfetch and other internet retailers plunge.

JERSEY CITY, N.J., July 6, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Vascular Disrupting Agents Market By Indications

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Vascular Disrupting Agents Market By...

Plinabulin plus pegfilgrastim had more efficacy than pegfilgrastim alone in ameliorating chemotherapy-induced neutropenia. The study was published as a preprint and has not yet been peer reviewed.

/PRNewswire/ -- The "Artificial Intelligence in Healthcare: Intellectual Property Landscape" report has been added to ResearchAndMarkets.coms offering. This...

/PRNewswire/ -- The "Artificial Intelligence in Healthcare: Intellectual Property Landscape" report has been added to ResearchAndMarkets.coms offering. This...